Navigation Links


Clintrax Global, Inc. Announces Addition to Executive Team

8/20/2014
RALEIGH, N.C. , Aug. 20, 2014 Clintrax Global, Inc., a worldwide provider of clinical research services located in Raleigh, NC , recently announced the addition of Bradford Evans as Vice President of Administration. As Vice President of Administration, Brad will oversee all corporate processes, including their alignment with company objectives and policies.  Prior... [Comments]

Early bottlenecks in developing biopharmaceutical products delay commercialization

8/20/2014
An analysis of patented university inventions licensed to biotechnology firms has revealed early bottlenecks on the path to commercialization. To open these roadblocks, the researchers suggest that better communication of basic research results during the discovery stage could lead to faster co... [Comments]Early bottlenecks in developing biopharmaceutical products delay commercialization

Unusual discovery leads to fascinating tuberculosis theory

8/20/2014
Grade school history lessons often have it that American Indians largely were wiped out by diseases such as whooping cough, chicken pox, influenza and tuberculosis brought to the New World by European explorers. One report says, while estimates vary, about 20 million people lived in the Americas shortly before Europeans arrived, and roughly 95 percent of them were killed by European diseases.... [Comments]

Seeing a molecule breathe

8/20/2014
For the first time, chemists have succeeded in measuring vibrational motion of a single molecule with a femtosecond time resolution. The study reveals how vibration of a single molecule differs from the behaviour of larger molecular groups. The study was performed at the University of California, Irvine, where post-doctoral researcher Eero Hulkko from the University of Jyvskyl works as... [Comments]

Neurotrope To Host Conference Call

8/20/2014
PLANTATION, Fla. , Aug. 20, 2014 Neurotrope, Inc. (OTCQB: NTRP) today announced that it will host a conference call to provide an update on Company activities. Access information:Date:Tuesday, August 26, 2014Time:4:30 p.m. Eastern daylight timeDial-in numbers:(888) 505-4369 (U.S. and Canada) or (719) 325-2315 Conference ID number: 9126599 Live web cast: www.neurotropebioscienc... [Comments]

New Project Is the ACME of Addressing Climate Change

8/20/2014
Livermore, California (PRWEB) August 20, 2014 High performance computing (HPC) will be used to develop and apply the most complete climate and Earth system model to address the most challenging and demanding climate change issues. Eight national laboratories, including Lawrence Livermore , are combining forces with the National Center for Atmospheric Research, four academic institutions... [Comments]

BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market

8/20/2014
BURLINGTON, Mass. , Aug. 20, 2014  Decision Resources Group finds that the vascular access device market in Brazil , Russia , India and China (BRIC) was valued at approximately $1.6 billion in 2013, roughly equal to the size of the United States market that year. Going forward, however, the BRIC market will experience much faster growth as a result of str... [Comments]

PAREXEL International To Present At Baird Healthcare Conference

8/20/2014
BOSTON , Aug. 20, 2014  PAREXEL International Corporation (NASDAQ: PRXL ) announced today that it will be presenting at the Baird Healthcare Conference in New York.  Ingo Bank , Senior Vice President and Chief Financial Officer, will be making a presentation on PAREXEL and discussing business developments at 4:40 p.m. EDT on Wednesday, Sept. 3, 2014. A live webca... [Comments]

6th Annual Personalized and Precision Medicine Conference Bringing Together Thought Leaders to Discuss Clinical Implementation, Dx Reimbursement, Big Data, and Sequencing

8/20/2014
San Francisco, CA (PRWEB) August 20, 2014 The 6th Annual Arrowhead Personalized and Precision Medicine Conference is being held on October 29-30 in San Francisco, CA. This year’s conference brings together fresh perspectives from industry, academic and government researchers and clinicians focused on addressing and solving the significant hurdles remaining in the space. In the twelve... [Comments]

Are Extractable and Leachables going Phase-Appropriate? New Webinar Hosted by Xtalks

8/20/2014
Toronto, Canada (PRWEB) August 20, 2014 Not long ago, it was more or less conventional wisdom that E&L studies should be performed late in the development cycle – even after the final container/closure system is known. But current regulatory trends suggest that, like many things GxP, expectations for early E&L data are on the rise. In recent years, multiple drug sponsors have been r... [Comments]

[next]
(Date:8/20/2014)... State University, the Wellcome Trust Sanger Institute and the ... Mycobacterium pinnipedii from skeletons found in Peru ... is a relative of the TB bacterium that affects ... These researchers assume that seals carried the pathogens from ... lions was unexpected" comments Sebastien Gagneux, from the Swiss ...
(Date:8/20/2014)... Health has awarded the Oklahoma Medical Research Foundation a ... anthrax and the bacteria,s effects on humans. , ... his colleagues have studied the human immune response to ... Human Immunology. The original funding came soon after anthrax-laced ... of the terrorist attacks of Sept. 11, 2001. ...
(Date:8/20/2014)... spiciness that is irresistible to some, but intolerable to ... their findings to develop a new drug candidate for ... inflammation or other problems. They reported their progress on ... in ACS, Journal of Medicinal Chemistry . , ... had pegged a compound called capsaicin as the active ...
Breaking Biology News(10 mins):$14.5 million grant awarded to continue anthrax studies 2
... release is available in German . ... been awarded this year,s Heinz Maier-Leibnitz Prizes. The relevant ... Germany,s most prestigious award for young scientists. The prizewinners ... Hanover, Dr. Wilhelm Hofmann, Psychology, University of Wrzburg, Dr. ...
... triggered by environmental stimuli and often occur in response to ... predisposition to develop these diseases, which highlights a role for ... high number of people with depression have a genetic change ... each other in the brain. Imaging of people with ...
... Williams boards ferries bound for North Carolina,s Outer Banks, the ... her the "Pollen Lady." Each spring from 2006 ... to the mainland, collecting pine pollen blown far offshore. She ... the most commonly planted tree in the southern United ...
Cached Biology News:Heinz Maier-Leibnitz Prizes 2010: 6 outstanding young researchers honored 2Heinz Maier-Leibnitz Prizes 2010: 6 outstanding young researchers honored 3Heinz Maier-Leibnitz Prizes 2010: 6 outstanding young researchers honored 4Depression associated with sustained brain signals 2Gone with the wind: Far-flung pine pollen still potent miles from the tree 2
... Varioskan is a high performance spectral ... and incubator. With the advanced SkanIt ... reliability for drug discovery assay development. ... fluorescence intensity, time-resolved fluorescence and photometric ...
Immulon 2 HB 1x8 Strip assembled, C-bottom; high binding irradiated surface to provide increased binding affinity for hydrophilic proteins and complexes....
... The Jouan RCT series of refrigerated cold ... to trapping of low volatility/aqueous solvents or ... RC10 and other vacuum concentrators/centrifugal evaporators. Also ... cooling systems such as used in electron ...
Immulon 2HB, Flat Bottom, 50/Bx; high binding irradiated surface to provide increased binding affinity for hydrophilic proteins and complexes....
Biology Products:
(Date:8/19/2014)... GLEN BURNIE, Md. , Aug. 19, 2014 /PRNewswire/ ... the clinical research industry, recently announced the formation of ... is pleased to announce the addition of Dr. ... Photo - http://photos.prnewswire.com/prnh/20140818/136957 ... insight across a variety of therapeutic areas and set ...
(Date:8/19/2014)... 2014 Sales Horizons, a leader in ... online sales skills training course to help companies ... clinical staff spend the majority of their time on ... center, or physician practice – providing support and education ... there? Sales Horizons believes clinical staff are and should ...
(Date:8/18/2014)... Aug. 18, 2014 BioElectronics Corporation ... consumer medical devices said that its EVP ... by CEOLIVE.TV as part of its Executive ... is available at http://ceolive.tv/bioelectronics-corp-otc-biel/biel-videos/2282-ceolive-tv-interview-bioelectronics-corp-otcqb-biel ... to investors the unique advantages of BioElectronics ...
(Date:8/18/2014)... NEW YORK , August 18, 2014 /PRNewswire/ ... report published by Transparency Market Research "Life Science ... Culture, Flow Cytometry, Electrophoresis, Chromatography, In-Vitro Diagnostic Reagents ... Research and Academic Institutions, Clinical Laboratories, and Forensic ... and Forecast, 2013 - 2019", the global life ...
Breaking Biology Technology:CSSi Appoints Dr. William E. Gannon, Jr. to Newly Formed Medical and Clinical Advisory Board 2CSSi Appoints Dr. William E. Gannon, Jr. to Newly Formed Medical and Clinical Advisory Board 3Sales Horizons Launches a New Online Sales Training Course for MedTech Clinical Staff to Develop Their Sales Skills 2Sales Horizons Launches a New Online Sales Training Course for MedTech Clinical Staff to Develop Their Sales Skills 3BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 2BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 3Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 2Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 3Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 4Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 5
... , ... WX ), a,leading pharmaceutical, biotechnology, and medical-device research ... United States,announced that it had been selected to the ... consecutive year. The list recognizes the 50,fastest-growing companies in ...
... , DURHAM, N.C., Nov. 27 ... water-soluble carbon nanotube-based cancer drug delivery system in Hyderabad, India. ... walls that allows for conjugation with cancer drugs, was developed ... conjugated carbon nanotubes serves as a drug delivery vehicle with ...
... , BOSTON, Nov. 25 Biotech firm Replikins Ltd., ... pandemic through the prediction, outbreak, and progress of the current H1N1 ... new data shows that the lethality of the H1N1 ("Swine Flu") ... the virus,s current outbreak in the spring of 2009 to resting ...
Cached Biology Technology:WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5